Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
每日一次服用 SGLT2 抑制剂恩格列净可减弱糖尿病 db/db 小鼠的肾纤维化标志物，但不会改善白蛋白尿
期刊:Scientific Reports
影响因子:3.8
doi:10.1038/srep26428
Linda A Gallo, Micheal S Ward, Amelia K Fotheringham, Aowen Zhuang, Danielle J Borg, Nicole B Flemming, Ben M Harvie, Toni L Kinneally, Shang-Ming Yeh, Domenica A McCarthy, Hermann Koepsell, Volker Vallon, Carol Pollock, Usha Panchapakesan, Josephine M Forbes
